Dr. Njuguna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1624 S I St
Ste 102
Tacoma, WA 98405Phone+1 253-428-8700Fax+1 253-383-3376
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2005 - 2009
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 2001 - 2004
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2001
Certifications & Licensure
WA State Medical License 2009 - 2026
NC State Medical License 2004 - 2013
CO State Medical License 2004 - 2005
IL State Medical License 2001 - 2005
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 8 citationsRapid clearance of rituximab may contribute to the continued high incidence of autoimmune hematologic complications of chemoimmunotherapy for chronic lymphocytic leukemiaClifton C. Mo, Ndegwa Njuguna, Paul V. Beum, Margaret A. Lindorfer, Berengere Vire
Haematologica. 2013-08-01 - 87 citationsActivation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1Yair Herishanu, Federica Gibellini, Ndegwa Njuguna, Inbal Hazan-Halevy, Mohammed Farooqui
Leukemia & Lymphoma. 2011-08-24 - 670 citationsThe lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemiaYair Herishanu, Patricia Pérez-Galán, Delong Liu, Angelique Biancotto, Stefania Pittaluga
Blood. 2011-01-13
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
